Screener
Sarepta Therapeutics, Inc. SRPT Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Total current liabilities | 502,908 | 1,095,290 |
| Long-term debt | 847,623 | 828,974 |
| Lease liabilities, net of current portion | 198,226 | 199,378 |
| Deferred revenue, net of current portion | 110,132 | 83,910 |
| Other non-current liabilities | 1,825 | 1,529 |
| Total liabilities | 1,660,714 | 2,209,081 |
| Commitments and contingencies (Note 16) | ||
| Stockholders’ equity: |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s contract liabilities, non-current?
- Sarepta Therapeutics, Inc. (SRPT) reported contract liabilities, non-current of $110.13M in Q2 2026.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s contract liabilities, non-current?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s contract liabilities, non-current has grown at a -33.9% compound annual growth rate (CAGR), from $663.49M to $83.91M.
- What does contract liabilities, non-current mean?
- Obligation to transfer goods or services for which payment has been received, expected to be satisfied beyond one year.
Ask your AI about Sarepta Therapeutics, Inc.'s contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude